AGP Executive Report
Last update: 8 hours agoSkin Health Survey: Galderma reports 9 in 10 people worldwide have skin quality concerns, with fine lines/wrinkles, dry and dull skin topping the list, and 85% saying it affects quality of life. Workplace Health Policy: Germany’s Merz reforms would require a doctor’s note from day one of sick leave, a move aimed at cutting prolonged absences and boosting productivity. Kidney Care Innovation: Xeltis says it has started European commercialization of aXess™, a living vascular access implant for hemodialysis, with a first commercial patient treated in Munich. Cancer Treatment Update: The FDA has approved durvalumab plus BCG for high-risk non-muscle-invasive bladder cancer, building on POTOMAC trial results. Knee Osteoarthritis Procedure: Charité researchers report a minimally invasive knee artery embolization approach can cut pain roughly in half over 12 months for patients who didn’t respond to standard care. Health Tech in Germany: German-developed AI tool Mira (with TUD Dresden and Heidelberg) reportedly outperformed physicians on diagnostic accuracy across multiple conditions in a Nature study. Food & Wellness Market Signals: A wave of wellness retreat growth and “battery-free sensors” market expansion points to continued investment in preventive health and monitoring.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.